Reviewed,
UniProtKB/Swiss-Prot Q01082 (SPTB2_HUMAN)
Last modified
July 7, 2009.
Version 99.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Spectrin beta chain, brain 1 Alternative name(s): Spectrin, non-erythroid beta chain 1 Beta-II spectrin Fodrin beta chain | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 2364 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane. |
| Subunit structure | Like erythrocyte spectrin, the spectrin-like proteins are capable to form dimers which can further associate to tetramers. The short form cannot bind to the axonal protein fodaxin. Interacts with ANK2. Ref.7 |
| Subcellular location | Cytoplasm › cytoskeleton By similarity. Cytoplasm › myofibril › sarcomere › M-band By similarity. Note: Colocalizes with ANK2 in a distinct intracellular compartment of neonatal cardiomyocytes By similarity. Isoform 2: Cell membrane; Peripheral membrane protein; Cytoplasmic side By similarity. |
| Tissue specificity | Isoform 2 is present in brain, lung and kidney (at protein level). Ref.2 |
| Post-translational modification | Isoform 2 is phosphorylated on Ser-8 and Ser-10 By similarity. |
| Sequence similarities | Belongs to the spectrin family. Contains 2 CH (calponin-homology) domains. Contains 1 PH domain. Contains 17 spectrin repeats. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Cytoplasm Cytoskeleton Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat |
| Ligand | Actin-binding Calmodulin-binding |
| Molecular function | Actin capping |
| PTM | Glycoprotein Phosphoprotein |
| Technical term | 3D-structure Complete proteome |
| Gene Ontology (GO) | |
| Biological process | barbed-end actin filament capping Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | M band Inferred from electronic annotation. Source: UniProtKB-SubCell nucleolusInferred from direct assay. Source: HGNC plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell spectrin Ref.1Traceable author statement. Source: ProtInc |
| Molecular function | actin binding Ref.1 Traceable author statement. Source: ProtInc calmodulin bindingInferred from electronic annotation. Source: UniProtKB-KW structural constituent of cytoskeleton Ref.1Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CSNK2A1 | P68400 | 1 | EBI-351584,EBI-347804 | |
| SPTA1 | P02549 | 2 | EBI-351561,EBI-375617 | |
| SPTAN1 | Q13813 | 1 | EBI-351584,EBI-351450 | |
| SPTAN1 | Q13813 | 1 | EBI-351561,EBI-351450 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Long (identifier: Q01082-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Short (identifier: Q01082-2) The sequence of this isoform differs from the canonical sequence as follows: 2141-2168: MAETVDTSEMVNGATEQRTSSKESSPIP → VSYRSQTYQNYKNFNSRRTASDQPWSGL 2169-2364: Missing. | ||||||
| Isoform 2 (identifier: Q01082-3) The sequence of this isoform differs from the canonical sequence as follows: 1-49: MTTTVATDYD...FERSRIKALA → MELQRTSSIS...QLEGRFKQLQ 2141-2225: MAETVDTSEM...KASSRSWHNV → VSYRSQTYQNYKNFNSRRTASDQPWSGL 2226-2364: Missing. | ||||||
| Note: Phosphorylated on Ser-8 (By similarity), Ser-10 and Ser-14. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 2364 | 2364 | Spectrin beta chain, brain 1 | PRO_0000073461 | ||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||
| Domain | 1 – 275 | 275 | Actin-binding | |||||||||||||||||||||||||
| Domain | 54 – 158 | 105 | CH 1 | |||||||||||||||||||||||||
| Domain | 173 – 275 | 103 | CH 2 | |||||||||||||||||||||||||
| Repeat | 276 – 384 | 109 | Spectrin 1 | |||||||||||||||||||||||||
| Repeat | 385 – 498 | 114 | Spectrin 2 | |||||||||||||||||||||||||
| Repeat | 499 – 608 | 110 | Spectrin 3 | |||||||||||||||||||||||||
| Repeat | 609 – 714 | 106 | Spectrin 4 | |||||||||||||||||||||||||
| Repeat | 715 – 819 | 105 | Spectrin 5 | |||||||||||||||||||||||||
| Repeat | 820 – 925 | 106 | Spectrin 6 | |||||||||||||||||||||||||
| Repeat | 926 – 1032 | 107 | Spectrin 7 | |||||||||||||||||||||||||
| Repeat | 1033 – 1139 | 107 | Spectrin 8 | |||||||||||||||||||||||||
| Repeat | 1140 – 1245 | 106 | Spectrin 9 | |||||||||||||||||||||||||
| Repeat | 1246 – 1350 | 105 | Spectrin 10 | |||||||||||||||||||||||||
| Repeat | 1351 – 1462 | 112 | Spectrin 11 | |||||||||||||||||||||||||
| Repeat | 1463 – 1562 | 100 | Spectrin 12 | |||||||||||||||||||||||||
| Repeat | 1563 – 1668 | 106 | Spectrin 13 | |||||||||||||||||||||||||
| Repeat | 1669 – 1775 | 107 | Spectrin 14 | |||||||||||||||||||||||||
| Repeat | 1776 – 1881 | 106 | Spectrin 15 | |||||||||||||||||||||||||
| Repeat | 1882 – 1987 | 106 | Spectrin 16 | |||||||||||||||||||||||||
| Repeat | 1988 – 2133 | 146 | Spectrin 17 | |||||||||||||||||||||||||
| Domain | 2197 – 2307 | 111 | PH | |||||||||||||||||||||||||
| Region | 1563 – 2093 | 531 | Interaction with ANK2 | |||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||
| Modified residue | 999 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||
| Modified residue | 1805 | 1 | Phosphotyrosine By similarity | |||||||||||||||||||||||||
| Modified residue | 1918 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 2102 | 1 | Phosphoserine Ref.9 Ref.10 Ref.11 Ref.13 Ref.14 Ref.15 | |||||||||||||||||||||||||
| Modified residue | 2115 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 2128 | 1 | Phosphoserine Ref.10 Ref.8 | |||||||||||||||||||||||||
| Modified residue | 2138 | 1 | Phosphoserine Ref.10 Ref.14 Ref.15 Ref.8 | |||||||||||||||||||||||||
| Modified residue | 2159 | 1 | Phosphothreonine Ref.15 | |||||||||||||||||||||||||
| Modified residue | 2160 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||
| Modified residue | 2164 | 1 | Phosphoserine Ref.13 Ref.15 | |||||||||||||||||||||||||
| Modified residue | 2165 | 1 | Phosphoserine Ref.15 Ref.8 | |||||||||||||||||||||||||
| Modified residue | 2169 | 1 | Phosphoserine Ref.9 Ref.13 Ref.15 Ref.8 Ref.12 | |||||||||||||||||||||||||
| Modified residue | 2187 | 1 | Phosphothreonine Ref.15 | |||||||||||||||||||||||||
| Modified residue | 2195 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||
| Modified residue | 2328 | 1 | Phosphothreonine Ref.15 | |||||||||||||||||||||||||
| Modified residue | 2341 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||
| Glycosylation | 2324 | 1 | O-linked (GlcNAc) By similarity | |||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||
| Alternative sequence | 1 – 49 | 49 | MTTTV…IKALA → MELQRTSSISGPLSPAYTGQ VPYNYNQLEGRFKQLQ in isoform 2. | VSP_026054 | ||||||||||||||||||||||||
| Alternative sequence | 2141 – 2225 | 85 | MAETV…SWHNV → VSYRSQTYQNYKNFNSRRTA SDQPWSGL in isoform 2. | VSP_026055 | ||||||||||||||||||||||||
| Alternative sequence | 2141 – 2168 | 28 | MAETV…SSPIP → VSYRSQTYQNYKNFNSRRTA SDQPWSGL in isoform Short. | VSP_000720 | ||||||||||||||||||||||||
| Alternative sequence | 2169 – 2364 | 196 | Missing in isoform Short. | VSP_000721 | ||||||||||||||||||||||||
| Alternative sequence | 2226 – 2364 | 139 | Missing in isoform 2. | VSP_026056 | ||||||||||||||||||||||||
| Natural variant | 1411 | 1 | D → H: dbSNP rs1052790. Ref.2 Ref.1 | VAR_032641 | ||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||
| Sequence conflict | 583 | 1 | R → W in BAD92985. Ref.3 | |||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||
| Helix | 174 – 186 | 13 | ||||||||||||||||||||||||||
| Turn | 187 – 189 | 3 | ||||||||||||||||||||||||||
| Beta strand | 196 – 199 | 4 | ||||||||||||||||||||||||||
| Helix | 200 – 202 | 3 | ||||||||||||||||||||||||||
| Helix | 206 – 215 | 10 | ||||||||||||||||||||||||||
| Helix | 217 – 219 | 3 | ||||||||||||||||||||||||||
| Helix | 222 – 224 | 3 | ||||||||||||||||||||||||||
| Helix | 230 – 245 | 16 | ||||||||||||||||||||||||||
| Helix | 253 – 256 | 4 | ||||||||||||||||||||||||||
| Beta strand | 257 – 260 | 4 | ||||||||||||||||||||||||||
| Helix | 263 – 277 | 15 | ||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Characterization of human brain cDNA encoding the general isoform of beta-spectrin." Hu R.J., Watanabe M., Bennett V. J. Biol. Chem. 267:18715-18722(1992) [PubMed: 1527002] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), VARIANT HIS-1411. Tissue: Brain. |
| [2] | "A novel isoform of beta-spectrin II localizes to cerebellar Purkinje-cell bodies and interacts with neurofibromatosis type 2 gene product schwannomin." Chen Y., Yu P., Lu D., Tagle D.A., Cai T. J. Mol. Neurosci. 17:59-70(2001) [PubMed: 11665863] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, VARIANT HIS-1411. |
| [3] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). Tissue: Brain. |
| [4] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed: 15815621] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Cloning of a portion of the chromosomal gene and cDNA for human beta-fodrin, the nonerythroid form of beta-spectrin." Chang J.G., Scarpa A., Eddy R.L., Byers M.G., Harris A.S., Morrow J.S., Watkins P., Shows T.B., Forget B.G. Genomics 17:287-293(1993) [PubMed: 8406479] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 293-1544. |
| [6] | "Identification of a novel C-terminal variant of betaII spectrin: two isoforms of betaII spectrin have distinct intracellular locations and activities." Hayes N.V.L., Scott C., Heerkens E., Ohanian V., Maggs A.M., Pinder J.C., Kordeli E., Baines A.J. J. Cell Sci. 113:2023-2034(2000) [PubMed: 10806113] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 2087-2168 (ISOFORM SHORT). Tissue: Skeletal muscle. |
| [7] | "Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes." Mohler P.J., Yoon W., Bennett V. J. Biol. Chem. 279:40185-40193(2004) [PubMed: 15262991] [Abstract] Cited for: INTERACTION WITH ANK2. |
| [8] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2128; SER-2138; SER-2165 AND SER-2169, MASS SPECTROMETRY. Tissue: Epithelium. |
| [9] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102 AND SER-2169, MASS SPECTROMETRY. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102; SER-2128 AND SER-2138, MASS SPECTROMETRY. Tissue: Epithelium. |
| [11] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102, MASS SPECTROMETRY. Tissue: Epithelium. |
| [12] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2169, MASS SPECTROMETRY. |
| [13] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102; SER-2164 AND SER-2169, MASS SPECTROMETRY. Tissue: Platelet. |
| [14] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102 AND SER-2138, MASS SPECTROMETRY. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2102; SER-2138; THR-2159; SER-2160; SER-2164; SER-2165; SER-2169; THR-2187; THR-2328 AND SER-2341, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10 AND SER-14 (ISOFORM 3), MASS SPECTROMETRY. |
| [16] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [17] | "Crystal structure of a calponin homology domain." Carugo K.D., Banuelos S., Saraste M. Nat. Struct. Biol. 4:175-179(1997) [PubMed: 9164454] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 173-280. |
| [18] | "Structural comparisons of calponin homology domains: implications for actin binding." Banuelos S., Saraste M., Carugo K.D. Structure 6:1419-1431(1998) [PubMed: 9817844] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS) OF 173-281. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M96803 mRNA. Translation: AAA60580.1. AF327441 mRNA. Translation: AAO15362.1. AB209748 mRNA. Translation: BAD92985.1. Different initiation. AC093110 Genomic DNA. Translation: AAY24229.1. AC092839 Genomic DNA. No translation available. S65762 mRNA. Translation: AAB28324.1. AJ005694 mRNA. Translation: CAA06678.1. AJ238723 Genomic DNA. Translation: CAB91088.1. | |||||||||||||||||||||||||
| IPI | IPI00005614. IPI00328230. IPI00333015. | ||||||||||||||||||||||||
| PIR | A44159. A47213. | ||||||||||||||||||||||||
| RefSeq | NP_003119.2. NP_842565.2. | ||||||||||||||||||||||||
| UniGene | Hs.503178 Hs.705692 | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| SMR | Q01082. Positions 2200-2305. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | Q01082. 19 interactions. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q01082. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | Q01082. | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENSG00000115306. Homo sapiens. [Contig view] | ||||||||||||||||||||||||
| GeneID | 6711. | ||||||||||||||||||||||||
| KEGG | hsa:6711. | ||||||||||||||||||||||||
| UCSC | uc002rxu.1. human. uc002rxx.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| GeneCards | GC02P054596. | ||||||||||||||||||||||||
| H-InvDB | HIX0002055. | ||||||||||||||||||||||||
| HGNC | HGNC:11275. SPTBN1. | ||||||||||||||||||||||||
| HPA | HPA012685. HPA013149. | ||||||||||||||||||||||||
| MIM | 182790. gene. | ||||||||||||||||||||||||
| PharmGKB | PA36104. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| HOVERGEN | Q01082. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | tgfbrpathway. TGF-beta receptor signaling. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q01082. | ||||||||||||||||||||||||
| Bgee | Q01082. | ||||||||||||||||||||||||
| CleanEx | HS_SPTBN1. | ||||||||||||||||||||||||
| GermOnline | ENSG00000115306. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR001589. Actinin_actin-bd_CS. IPR001715. Calponin_act_bd. IPR011993. PH_type. IPR001849. Pleckstrin_homology. IPR018159. Spectrin/alpha-actinin. IPR016343. Spectrin_bsu. IPR001605. Spectrin_PH. IPR002017. Spectrin_repeat. [Graphical view] | ||||||||||||||||||||||||
| Gene3D | G3DSA:1.10.418.10. Calponin-homology. 2 hits. G3DSA:2.30.29.30. PH_type. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF00307. CH. 2 hits. PF00169. PH. 1 hit. PF00435. Spectrin. 17 hits. [Graphical view] | ||||||||||||||||||||||||
| PIRSF | PIRSF002297. Spectrin_beta_subunit. 1 hit. | ||||||||||||||||||||||||
| PRINTS | PR00683. SPECTRINPH. | ||||||||||||||||||||||||
| SMART | SM00033. CH. 2 hits. SM00233. PH. 1 hit. SM00150. SPEC. 17 hits. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS00019. ACTININ_1. 1 hit. PS00020. ACTININ_2. 1 hit. PS50021. CH. 2 hits. PS50003. PH_DOMAIN. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||
| NextBio | 26172. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | SPTB2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q01082 Secondary accession number(s): O60837 Q8IX99 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


